TickerFacts.

Rhythm Pharmaceuticals, Inc. (RYTM): Revenue

Annual figures by period end, from SEC filings.

$189.76M
Year ended 2025-12-31
$239.92M
Trailing 12 months to 2026-06-30
+100.2%
3-year compound annual growth
2016-12-31: $02017-12-31: $02018-12-31: $02019-12-31: $02020-12-31: $02021-12-31: $3.15M2022-12-31: $23.64M2023-12-31: $77.43M2024-12-31: $130.13M2025-12-31: $189.76M$189.76M
2016-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$189.76M+45.8%2026-02-26, From 2025-01-01
2024-12-31$130.13M+68.1%2026-02-26, From 2024-01-01
2023-12-31$77.43M+227.6%2026-02-26, From 2023-01-01
2022-12-31$23.64M+649.5%2025-02-28, From 2022-01-01
2021-12-31$3.15Mn/a2024-02-29, From 2021-01-01
2020-12-31$0n/a2021-03-01, From 2020-01-01
2019-12-31$0n/a2021-03-01, From 2019-01-01
2018-12-31$0n/a2021-03-01, From 2018-01-01
2017-12-31$0n/a2020-03-02, From 2017-01-01
2016-12-31$0n/a2019-03-08, From 2016-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Rhythm Pharmaceuticals, Inc. (RYTM)2025-12-31$189.76M+45.8%
Maravai Lifesciences Holdings, Inc. (MRVI)2025-12-31$185.74M-28.3%
Stoke Therapeutics, Inc. (STOK)2025-12-31$184.42M+404.5%
Lifevantage Corp (LFVN)2026-06-30$182.59M-20.1%
Cryoport, Inc. (CYRX)2025-12-31$176.18M+12.4%
Phathom Pharmaceuticals, Inc. (PHAT)2025-12-31$175.11M+216.9%
Syndax Pharmaceuticals Inc (SNDX)2025-12-31$172.35M+627.8%
Amarin Corp PLC (AMRN)2025-12-31$213.65M-6.5%
Vanda Pharmaceuticals Inc. (VNDA)2025-12-31$216.10M+8.7%

Compare RYTM, MRVI, STOK, LFVN side by side · Screen every company in Pharmaceutical Preparations ↗